586 related articles for article (PubMed ID: 22404824)
1. Unclassified renal cell carcinoma: a report of 56 cases.
Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
4. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
5. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
6. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
[TBL] [Abstract][Full Text] [Related]
8. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
12. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
16. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
17. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
18. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
Dall'Oglio MF; Antunes AA; Sarkis AS; Crippa A; Leite KR; Lucon AM; Srougi M
BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
[TBL] [Abstract][Full Text] [Related]
19. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
20. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
